--- title: "Ukrainian Ministry of Health: No Systemic Medicine Shortage, but Russian Warehouse Attacks Cause Isolated Disruptions" description: "The Ukrainian Ministry of Health reported no systemic medicine shortages amid Russian attacks on pharmaceutical infrastructure. The government simplified storage and import control rules for drugs." date: 2026-10-28T20:56:51.106Z lang: en url: https://xab.info/en/posts/ukraine-no-systemic-medicine-shortage-ministry tags: [ukraine, pharmaceuticals, drug-supply, ministry-of-health, government, logistics, war-impact] author: "Inna Kinsheva" publisher: "XAB.info" --- # Ukrainian Ministry of Health: No Systemic Medicine Shortage, but Russian Warehouse Attacks Cause Isolated Disruptions ![Pharmacist in a white coat and blue gloves checking medicine boxes in a warehouse](https://xab.info/media/2026/10/28/ukrajina-bez-sistemnogo-deficita-lekarstv-minzdrav/ukrajina-bez-sistemnogo-deficita-lekarstv-minzdrav-1.webp) ## Key Points - The Ukrainian Ministry of Health states there is no systemic medicine shortage, but warehouse shelling causes isolated temporary disruptions for certain drugs. - Cabinet Resolution No. 1062 of August 26, 2026, expanded the ability to use additional warehouse facilities for storing and shipping medicines. - Cabinet Resolution No. 1254 of October 13, 2026, simplified state quality control procedures for imported drugs and introduced special conditions for re-importing the same batch. - By early October 2026, 78% of medical facilities in the capable network could operate autonomously during power, heat, and water outages. The Ukrainian pharmaceutical sector continues to operate amid regular Russian strikes on warehouse, production, and logistics infrastructure. According to the Ministry of Health, despite the risk of facility damage, stock losses, and disrupted supply routes, there is no systemic shortage of medicines in the country. At the same time, the agency records isolated temporary difficulties with the supply of certain drugs, which occur immediately after shelling of warehouses and distribution centers. ### Ministry Position: Swift Response Instead of Panic «There is no systemic shortage of medicines in Ukraine. At the same time, isolated temporary difficulties with the supply of certain drugs do arise,» the Ministry of Health stated. According to the agency's explanation, its current work in cooperation with manufacturers, importers, and distributors focuses on rapidly responding to such disruptions, restoring supplies, and reducing the risk of their recurrence. Thus, the official course is built on the principle of supply continuity: even with local supply chain failures, the state aims to prevent them from escalating into a persistent shortage. ### Expanding Storage Capacities: Resolution No. 1062 To reduce the risk of simultaneous loss of large inventories, the government expanded options for receiving, storing, and shipping medicines from additional warehouse facilities. The corresponding Cabinet of Ministers Resolution No. 1062 of August 26, 2026, allows companies under certain conditions to use premises whose details are absent from the licensing registry or belong to another licensee. At the same time, mandatory compliance with quality and traceability requirements is maintained, preventing a lowering of standards amid logistics simplification. ### Simplifying Import Control: Resolution No. 1254 The second key change was approved by Resolution No. 1254 of October 13, 2026. The document concerns state quality control of medicines imported into Ukraine and provides for the simplification of certain inspection procedures for imported drugs, as well as special control conditions for the re-importation of the same batch. The Ministry of Health explains that these decisions are designed to deliver medicines to pharmacies and medical facilities faster and support supply continuity without weakening drug quality requirements. ### Broader Context: Medical Institution Autonomy and Scientific Base Pharmaceutical logistics measures fit into a broader healthcare resilience plan. As of early October 2026, 78% of medical facilities in Ukraine's capable network could already operate fully autonomously during power, heat, and water outages. Simultaneously, the country preserves its scientific potential in pharmaceuticals: back in 2021, Ukrainian scientists developed a COVID-19 vaccine prototype that showed 93% neutralizing activity in animal tests, although further development was paused. According to authorities, the combination of these factors helps keep the medicine market operational even under ongoing attacks on infrastructure. ## Fact-Check & Sources - [РФ обстреливает склады лекарств: в Минздраве объяснили, угрожает ли Украине дефицит препаратов](https://www.rbc.ua/ukr/news/rf-obstrilyue-skladi-likiv-moz-poyasnili-1793201219.html) - Direct quote from the Ministry of Health on the absence of a systemic shortage and the presence of isolated disruptions; mentions Cabinet resolutions No. 1062 of Aug 26, 2026, and No. 1254 of Oct 13, 2026; context on 78% medical facility autonomy and the 2021 vaccine prototype. ## FAQ ### Is there a systemic shortage of medicines in Ukraine? According to the Ministry of Health, there is no systemic shortage. Due to Russian shelling of warehouse and logistics infrastructure, only isolated temporary difficulties with the supply of certain drugs occur. ### What does Cabinet of Ministers Resolution No. 1062 of August 26, 2026, provide for? It expands options for receiving, storing, and shipping medicines from additional warehouse facilities, including those not listed in the licensing registry or belonging to another licensee, while maintaining quality and traceability requirements. ### What is Resolution No. 1254 of October 13, 2026, about? The document simplifies certain state quality control procedures for medicines imported into Ukraine and establishes special control conditions when re-importing the same batch of drugs. ### What is the goal of the government changes in pharmaceutical supply? According to the Ministry of Health, the decisions aim to deliver medicines to pharmacies and medical facilities faster, reduce the risk of simultaneous large inventory loss, and maintain supply continuity without weakening quality standards.